Acta Pharmaceutica Sinica B : Impact Factor & More
eISSN: 2211-3843pISSN: 2211-3835
Open AccessShare this on:
Key Metrics
CiteScore 
15.9
Eigenfactor
< 0.001
Impact Factor
10 - 15
Scite Index
0.95 5-Year SI
SJR
Q1Pharmacology, Toxicology and Pharmaceutics (all)
SNIP
2.59
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Acta Pharmaceutica Sinica B
Acta Pharmaceutica Sinica B Journal Specifications
| Overview | |
| Publisher | INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES |
| Language | English |
| Frequency | Bi-monthly |
| Publication Time | 19 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Insititute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association |
| Frequency | Bi-monthly |
| Publication Start Year | 2011 |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Acta Pharmaceutica Sinica B ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Acta Pharmaceutica Sinica B
PYGL-driven glycogenolysis impairs microglial autophagic flux via SNAP29 O-GlcNAcylation in Alzheimer's disease.
- 1 Jul 2026
- Acta pharmaceutica Sinica. B
A probiotic–drug cascade system for inflammatory bowel disease via tryptophan metabolism and gut microbiome remodeling
- 1 Jul 2026
- Acta Pharmaceutica Sinica B
Targeting FAPα-positive hepatic stellate cells ameliorates the formation of pre-metastatic niche.
- 1 Jul 2026
- Acta pharmaceutica Sinica. B
In vitro transcribed circRNA as a therapeutic agent for cancer.
- 1 Jul 2026
- Acta pharmaceutica Sinica. B
Reaction-aware molecular representation learning: Toward generalizable artificial intelligence for enzymatic catalysis.
- 1 Jul 2026
- Acta pharmaceutica Sinica. B
Targeting bacterial phosphotransferase system to prevent the dissemination of antibiotic resistance genes.
- 1 Jul 2026
- Acta pharmaceutica Sinica. B
PYGL-driven glycogenolysis impairs microglial autophagic flux via SNAP29 O-GlcNAcylation in Alzheimer's disease.
- 1 Jul 2026
- Acta pharmaceutica Sinica. B
A probiotic–drug cascade system for inflammatory bowel disease via tryptophan metabolism and gut microbiome remodeling
- 1 Jul 2026
- Acta Pharmaceutica Sinica B
Targeting FAPα-positive hepatic stellate cells ameliorates the formation of pre-metastatic niche.
- 1 Jul 2026
- Acta pharmaceutica Sinica. B
In vitro transcribed circRNA as a therapeutic agent for cancer.
- 1 Jul 2026
- Acta pharmaceutica Sinica. B
Reaction-aware molecular representation learning: Toward generalizable artificial intelligence for enzymatic catalysis.
- 1 Jul 2026
- Acta pharmaceutica Sinica. B
Targeting bacterial phosphotransferase system to prevent the dissemination of antibiotic resistance genes.
- 1 Jul 2026
- Acta pharmaceutica Sinica. B
FAQs on Acta Pharmaceutica Sinica B
How long has Acta Pharmaceutica Sinica B been actively publishing? 
What is the publishing frequency of Acta Pharmaceutica Sinica B?
How many articles did Acta Pharmaceutica Sinica B publish last year?
What is the eISSN & pISSN for Acta Pharmaceutica Sinica B?
What is Citescore for Acta Pharmaceutica Sinica B?
What is SNIP score for Acta Pharmaceutica Sinica B?
What is the SJR for Acta Pharmaceutica Sinica B?
Who is the publisher of Acta Pharmaceutica Sinica B?
